Back to Search
Start Over
FDA grants Lilly's Retevmo accelerated approval for thyroid cancer
- Source :
- The Fly. May 29, 2024
- Publication Year :
- 2024
-
Abstract
- The Food and Drug Administration said it granted accelerated approval to Eli Lilly's selpercatinib, named Retevmo, for pediatric patients two years of age and older with advanced or metastatic medullary [...]
- Subjects :
- United States. Food and Drug Administration
Eli Lilly and Co.
Metastasis -- Genetic aspects -- Care and treatment
Cancer -- Genetic aspects
Children -- Health aspects
Drug approval
Thyroid cancer -- Care and treatment -- Genetic aspects
Pharmaceutical industry
Business
News, opinion and commentary
Retevmo (Medication)
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.795662386